Macrophage-mediated phagocytosis of tumor cells is restored after treatment with CD47 antibodies, and this macrophage-mediated phagocytosis process is further enhanced in the presence of chemotherapeutic drugs, suggesting that lower CD47 expression are more likely to benefit from adjuvant TACE treatment [35,130]. The gene discussed is CD47; the disease is neoplasm.